BioStock: PHI expands market potential with regenerative medicine opportunity

Phase Holographic Imaging’s sales have doubled in one year, according to the company’s annual report published this week. However, it generates even more confidence for the company because PHI now addresses the entire spectrum of the healthcare market, not just medical research. The company aims to become a welded link in the value chain of modern medicine in general and regenerative medicine in particular. To find out more, BioStock contacted the company’s CFO, Patrik Eschricht.

Read the interview with PHI's CFO Patrik Eschricht at biostock.se:

PHI expands market potential with regenerative medicine opportunity - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/